The acceptability of nicotine containing products as alternatives to cigarettes: Findings from two pilot studies

Harm Reduction Journal

Volumn 8, Issue , 2011, Pages

  Borland, Ron ^a   Li, Lin ^a   Mortimer, Kevin ^b   McNeil, Ann ^b   King, Bill ^a   O'Connor, Richard J ^c  

^a CANCER EPIDEMIOLOGY CENTRE   (Australia)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARIVA; CATCH; NICOBATE; NICOTINE; OLIVER TWIST; STONEWALL; SWEDISH SNUS; UNCLASSIFIED DRUG;

ADULT; ARTICLE; AUSTRALIA; CIGARETTE SMOKING; FEMALE; HUMAN; LOZENGE; MAJOR CLINICAL STUDY; MALE; NICOTINE REPLACEMENT THERAPY; POSTAL MAIL; SMOKELESS TOBACCO; SMOKING CESSATION; TOBACCO DEPENDENCE; UNITED KINGDOM;

EID: 80053905760     PISSN: None     EISSN: 14777517     Source Type: Journal    
DOI: 10.1186/1477-7517-8-27     Document Type: Article

References (9)

1. Martin EG, Warner KE, Lantz PM. Tobacco harm reduction: what do the experts think?. Tob Control 2004, 13:123-128. 10.1136/tc.2003.006346, 1747871, 15175526.
2. Schneider NG, Cortner C, Justice M, Gould JL, Amor C, Harman N, Kleinman L, Olmstead RE. Preferences among five nicotine treatments based on information versus sampling. Nicotine Tob Res 2008, 10:179-186. 10.1080/14622200701767837, 18188758.
3. Carpenter MJ, Gray KM. A pilot randomized study of smokeless tobacco use among smokers not interested in quitting: changes in smoking behavior and readiness to quit. Nicotine Tob Res 2010, 12:136-143. 10.1093/ntr/ntp186, 2816197, 20053788.
4. Cobb CO, Weaver MF, Eissenberg T. Evaluating the Acute Effects of Oral, Non-combustible Potential Reduced Exposure Products Marketed to Smokers. Tob Control 2010, 19:367-73. 10.1136/tc.2008.028993, 19346218.
5. O'Connor R, Norton K, Bansal-Travers M, Mahoney M, Cummings KM, Borland R. US smokers' reactions to a brief trial of oral nicotine products. Harm Reduct J 2011, 8:1. 10.1186/1477-7517-8-1, 3032705, 21219609.
6. Rennard SI, et al. Efficacy of the Nicotine Inhaler in Smoking Reduction: A Double-Blind, Randomized Trial. Nicotine Tob Res 2006, 8:555-564. 10.1080/14622200600789916, 16920653.
7. Gartner CE, Jimenez-Soto EV, Borland R, O'Connor RJ, Hall WD. Are Australian smokers interested in using low nitrosamine smokeless tobacco for harm reduction?. Tobacco Control 2010, 19:451-6. 10.1136/tc.2009.033670, 20671083.
8. Borland R. A strategy for controlling the marketing of tobacco products: a regulated market model. Tob Control 2003, 12:374-382. 10.1136/tc.12.4.374, 1747803, 14660771.
9. Gartner CE, Hall WD, Vos T, Bertram MY, Wallace AL, Lim SS. Assessment of Swedish snus for tobacco harm reduction: an epidemiological modeling study. Lancet 2007, 369:2010-4. 10.1016/S0140-6736(07)60677-1, 17498798.